Entero Healthcare Solutions Limited has announced the conclusion of Mr. Rajesh Shashikant Dalal’s tenure as a Non-Executive Independent Director. His term officially ended at the close of business on August 24, 2026. Consequently, Mr. Dalal has stepped down from his roles as Chairperson of the Nomination and Remuneration Committee, Stakeholders Relationship Committee, and as a member of the Audit Committee. The company expressed its sincere appreciation for his contributions.
Director’s Tenure Concludes
Entero Healthcare Solutions Limited has formally notified the stock exchanges regarding the conclusion of Mr. Rajesh Shashikant Dalal’s tenure as a Non-Executive Independent Director. This marks the end of his service to the company, effective from the close of business hours on August 24, 2026.
Committee Changes
Following the conclusion of his tenure, Mr. Dalal has ceased to hold his positions within the company’s committees. This includes stepping down as the Chairperson of the Nomination and Remuneration Committee and the Stakeholders Relationship Committee. He also ceases to be a member of the Audit Committee. These changes are effective from the same date, August 24, 2026.
Appreciation for Service
The company has taken this opportunity to acknowledge and record its sincere appreciation for the valuable guidance and significant contributions provided by Mr. Rajesh Shashikant Dalal during his time as a Non-Executive Independent Director. His leadership and insights were considered instrumental during his service.
Disclosure Details
The detailed information as required by the relevant regulations, including the reason for the change and the effective date, has been provided in the annexure to this disclosure. The document confirms the completion of Mr. Dalal’s tenure as an Independent Director on August 24, 2026.
Source: BSE
